Skip to main content
Top
Published in: Angiogenesis 2/2020

01-05-2020 | Retraction Note

Retraction Note to: The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4

Authors: Hua Zhou, Ying-Hua Yang, John R. Basile

Published in: Angiogenesis | Issue 2/2020

Login to get access

Excerpt

The Editors-in-Chief have retracted this article [1] following an investigation by the University of Maryland. The institution found that in Fig. 1c, the graph showing PDGF-B does not match the original data for the 24-h time point. The graph shows the value to be over 1000 pg/ml, but the original data have a value of 106.626. In Fig. 1f, the data were entered manually to create the standard deviation bars. The data manually entered do not match the original data. When the standard deviations for the original data were calculated, the p values were no longer significant using a paired Student t test. In Fig. 2c, the original data do not match the published data. In Fig. 4b, the images in the first lane and the fifth lane are from the same micrograph (i.e., the same set of conditions). However, the published figure claims that they are different conditions. The metadata in this figure also shows different cell lines than those noted in the article. The first and last images are labelled as “Du145 shAR3 anti AR3.jpg”. The second image is labelled as “Du145 shAR8 anti AR8.jpg”. The third image is labelled as “Cos1 mARs3 mS3-2 antibody-2.jpg.” The fourth image is labelled as “R1 3634 bleed.jpg”. Due to these errors, the Editors-in-Chief have found that the results are no longer reliable. …
Metadata
Title
Retraction Note to: The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4
Authors
Hua Zhou
Ying-Hua Yang
John R. Basile
Publication date
01-05-2020
Publisher
Springer Netherlands
Published in
Angiogenesis / Issue 2/2020
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-020-09710-4

Other articles of this Issue 2/2020

Angiogenesis 2/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.